- Decipher the genetic and epigenomic mechanisms regulating photoreceptor gene expression, development and maintenance.
- Understand pathogenesis underlying blinding disease linked to mutations in photoreceptor transcription factors, particularly the Cone-Rod-Homeobox protein CRX.
- Develop mechanism-based therapy strategies for treating CRX-associated photoreceptor disease.
Rod and cone photoreceptors are light-sensing neurons essential for our vision. Their development and maintenance require appropriate expression of a set of specific genes while silencing others. Over-expression and under-expression of certain genes, such as the visual pigment Rhodopsin, can lead to photoreceptor developmental defects or degeneration.
The major goal of our research is to elucidate the molecular mechanisms controlling the expression of photoreceptor genes and how genetic mutations cause gene mis-regulation and defects impacting photoreceptor cell biology and survival. We and others have identified a network of photoreceptor-specific transcription factors (TF) acting along with CRX and chromatin modulators that are essential for regulating target gene expression by binding to specific genomic sites called cis–regulatory elements (CREs), found in gene promoters, enhancers and other sites.
Our current research focuses on 1) deciphering the regulatory grammar of CRX-CRE interactions and the output that determines where, when and how much each photoreceptor gene is expressed; 2) understanding how mutations in either CRX or CREs disrupt the normal regulation and cause photoreceptor diseases. In vivo and ex vivo functional genomics and high-throughput analyses are being used. Examples are listed below:
- RNAseq transcriptome analyses from bulk cell populations to single cells.
- ChIPseq targetome analyses for TF binding and histone modifications.
- ATACseq for chromatin DNA accessibility.
- 4Cseq interactome combined with DNA & RNA FISH to study enhancer-promoter contacts and genomic organization in the nucleus.
- CREseq or massively-parallel-reporter-assays (MPRAs) for functional CREs in the genome, particularly those bound by CRX.
- CRISPR-Cas9/gRNA mediated genome-wide screens for CREs essential for photoreceptor cell fate.
- Generate mouse models for CRX-linked diseases and investigate the pathogenic mechanisms at morphological, electrophysiological and molecular levels.
- Develop and test new strategies to correct visual defects caused by human CRX mutations.
Rods and cones are special neurons carrying out phototransduction that converts the light signal into neuronal signal. Rods are responsible for night vision, while cones are responsible for color vision and visual acuity. Both have a unique structure called Outer Segment (OS) where opsins, the visual pigments, are localized (Fig 1).
Fig 1: Rods and Cones in mammalian retina. A) A human retinal section showing three neuronal cell layers: outer nuclear layer (ONL) containing the nucleus of rods and cones; inner nuclear layer (INL) containing the nucleus of bipolar, horizontal and amacrine and Muller glial cells; ganglion cell layer (GCL). B) Diagram of rod and cone structure. C) Scanning EM showing the outer segments.
The genetic program controlling rod/cone cell fate is referred as photoreceptor gene-regulatory-network (GRN), built on a set of specific transcription factors (TFs) (Fig 2, left panel) that bind to non-coding DNA regions so called cis-regulatory elements (CREs) (Fig 2, right panel) to determine where, when and how much each gene is expressed.
Key transcription factors (TFs) ➨ Cis-Regulatory Elements (CREs)
Fig 2: Photoreceptor Gene-Regulatory-Network (GRN). Left: During development, key rod/cone TFs are activated in CRX-expressing cells (photoreceptor precursor) and act with CRX to specify rod versus cone cell fate. Right: Each target gene is regulated by interactions among TF-bound cis-regulatory elements (CREs). The chromatin containing these CREs/genes undergoes multiple levels of genomic organization in the nucleus as modeled in A-D: By forming gene loops, the promoter of a gene interacts with its proximal enhancer (A), distal enhancers (B), and additional long-range enhancers (C). The whole genome in the nucleus is further organized into distinct domains and active/silent compartments and territories (D).
CRX is an otd/OTX-like homeodomain TF predominantly expressed in rods, cones (Fig 3A) and their precursors. CRX is essential for photoreceptor gene expression, development and maintenance. In Crx knockout mice (Crx-/-), rods/cones fail to generate proper structure and function due to gene misregulation, leading to “blindness” and retinal degeneration. CRX has a N-terminal DNA-binding homeodomain and C-terminal transactivation domains (Fig 3B). CRX acts by 1) binding to approximately six thousand CREs in the genome, 2) recruiting co-activators (epigenetic regulators) to a subset of CREs for local chromatin remodeling, and 3) activating transcription of target genes along with other TFs (Fig 3C).
Fig 3: CRX acts in rods/cones to regulate gene expression. (A) Immunostaining of a monkey retinal section, showing CRX (purple) is localized to the rod/cone nucleus (Blue-nucleus, Green-rod OS, Yellow-cone OS). (B) CRX contains two major functional domains and binds to a consensus DNA motif. (C) Model for CRX mechanism of action: CRX recruits epigenetic regulators, such as histone acetyltransferase (HAT), to configure an “open” chromatin at target genes, and activates transcription by interacting with other TFs and the RNA Pol II transcription machinery (adapted from Peng & Chen, 2007). CRX-mediated chromatin remodeling occurs at the level of DNA accessibility, histone modifications and long-range genomic interactions (Peng & Chen 2011; Ruzycki et al, 2018).
Mutations in the human CRX gene are associated with autosomal dominant and de novo photoreceptor diseases varying in age onset and phenotype severity, including Leber congenital amaurosis (LCA), cone-rod dystrophy (CRD) and retinitis pigmentosa (RP). Affected cones and rods show developmental abnormalities and degeneration. No treatment is currently available. Disease-causing mutations distribute along CRX protein and can be divided into four classes based on biochemical characteristics and pathogenic mechanisms of mutant proteins (Fig 4).
Fig 4: Four classes of disease-causing human CRX mutations and available animal models (adapted from Tran & Chen).
Meet The Team
Previous Lab Members
Inez Oh, Ph.D. 2016-2019 – Postdoctoral Research Associate.
Project: RNA metabolism in normal and diseased retinas
Current Position: Staff Scientist, Institute for Informatics, Washington University.
Philip A. Ruzycki Ph.D. 2012-2017 – Ph.D. stduent in Molecular Genetic & Genomics
Project: Epigenetic regulation of photoreceptor gene expression.
Current position: Instructor, Ophthalmology & Vision Sciences, Washington University
Diana S. Brightman, Ph.D. 2010-2016 – Ph.D. student in Molecular Cell Biology.
Project: Histone methyltransferases and demethylases in retinal development.
Current position: Genetic Conselor, Cincinnati Children’s Hospital.
Nicholas M.A. Tran, Ph.D. 2008-2014 – Ph.D. student in Molecular Genetics & Genomics
Project: The mechanisms by which human CRX mutations cause dominant retinopathies.
Current position: Postdoctoral Associate with Dr. Josh Sanes at Harvard University
Guang-Hua Peng, M.D., Ph.D. 2002-2011 – Senior Staff Scientist.
Current position: Professor, Hernan University School of Med, China
Xin Fang, B.S. 2017-2018 – Research Technician II
Project: The histone methyltransferases MLL1 and MLL2 in retinal development and maintenance.
Current position: Dental student, University of the Pacific Dugoni School of Dentistry
Courtney D. Linne, B.A. 2016-2017 – Research Technician II and Undergraduate Research Assistant.
Project: Animal models of CRX-associated blinding diseases.
Current position: M.D./Ph.D. student, University of Cincinnati College of Medicine.
Hui Wang, M.D. 2006-2013 – Research Technician II.
Project: Mouse models of blinding diseases.
Rachel L. Grant, B.A. 2013-2015 – Undergraduate Research Assistant
Project: The histone methyltransferase MLL1 in retinal development and maintenance.
Current position: Ph.D. student in Developmental Biology, Stanford University.
Ray Suzuki, B.A. 2011-2013 – Undergraduate Research Assistant
Project: The histone methyltransferase MLL1 in retinal development and maintenance.
Current position: Technical Consultant, Phenomenex Company.
Chen Lab Photo Album
- MLL1 is essential for retinal neurogenesis and horizontal inner neuron integrity. Brightman DS, Grant RL, Ruzycki PA, Suzuki R, Hennig AK, Chen S. Scientific reports. 2018; 8(1):11902.
- CRX directs photoreceptor differentiation by accelerating chromatin remodeling at specific target sites. Ruzycki PA, Zhang X, Chen S. Epigenetics & chromatin. 2018; 11(1):42.
- Crx-L253X Mutation Produces Dominant Photoreceptor Defects in TVRM65 Mice. Ruzycki PA, Linne CD, Hennig AK, Chen S. Investigative ophthalmology & visual science. 2017; 58(11):4644
- CrxRdy Cat: A Large Animal Model for CRX-Associated Leber Congenital Amaurosis.Occelli LM, Tran NM, Narfström K, Chen S, Petersen-Jones SM. Investigative Ophthalmology & Visual Science. 2016; 57(8):3780-92.
- Nrl-Cre transgenic mouse mediates loxP recombination in developing rod photoreceptors. Brightman DS, Razafsky D, Potter C, Hodzic D, Chen S. Genesis 2016; 54(3):129-35.
- Graded gene expression changes determine phenotype severity in mouse models of CRX-associated retinopathies. Ruzycki PA, Tran NM, Kefalov VJ, Kolesnikov AV, Chen S. Genome Biology. 2015; 16:171.
- The transcription factor GTF2IRD1 regulates the topology and function of photoreceptors by modulating photoreceptor gene expression across the retina. Masuda T, Zhang X, Berlinicke C, Wan J, Yerrabelli A, Conner EA, Kjellstrom S, Bush R, Thorgeirsson SS, Swaroop A, Chen S, Zack DJ. Journal of Neuroscience 2014; 34(46):15356-68.
- Mechanisms of blindness: animal models provide insight into distinct CRX-associated retinopathies. Tran NM, Chen S. Developmental Dynamics. 2014; 243(10):1153-66.
- Mechanistically distinct mouse models for CRX-associated retinopathy. Tran NM, Zhang A, Zhang X, Huecker JB, Hennig AK, Chen S. PLoS Genetics. 2014; 10(2):e1004111.
- Transcription coactivators p300 and CBP are necessary for photoreceptor-specific chromatin organization and gene expression. Hennig AK, Peng GH, Chen S. PLoS One. 2013; 8(7):e69721.
- Active opsin loci adopt intrachromosomal loops that depend on the photoreceptor transcription factor network. Peng GH, Chen S. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108(43):17821-6.
- Pias3-dependent SUMOylation controls mammalian cone photoreceptor differentiation. Onishi A, Peng GH, Chen S, Blackshaw S. Nature Neuroscience. 2010; 13(9):1059-65